Recent Approaches to Antifungal Therapy for Invasive Mycoses
- 11 March 2009
- journal article
- review article
- Published by Wiley in ChemMedChem
- Vol. 4 (3), 310-323
- https://doi.org/10.1002/cmdc.200800353
Abstract
Invasive fungal infections with primary and opportunistic mycoses have become increasingly common in recent years and pose a major diagnostic and therapeutic challenge. They represent a major area of concern in today's medical fraternity. The occurrence of invasive fungal diseases, particularly in AIDS and other immunocompromised patients, is life-threatening and increases the economic burden. Apart from the previously known polyenes and imidazole-based azoles, newly discovered triazoles and echinocandins are more effective in terms of specificity, yet some immunosuppressed hosts are difficult to treat. The main reasons for this include antifungal resistance, toxicity, lack of rapid and microbe-specific diagnoses, poor penetration of drugs into sanctuary sites, and lack of oral or intravenous preparations. In addition to combination antifungal therapy, other novel antimycotic treatments such as calcineurin signaling pathway blockers and vaccines have recently emerged. This review briefly summarizes recent developments in the pharmacotherapeutic treatment of invasive fungal infections.This publication has 105 references indexed in Scilit:
- In Vitro and In Vivo Antifungal Activities of T-2307, a Novel ArylamidineAntimicrobial Agents and Chemotherapy, 2008
- Measurement of Voriconazole Activity against Candida albicans , C. glabrata , and C. parapsilosis Isolates Using Time-Kill Methods Validated by High-Performance Liquid ChromatographyAntimicrobial Agents and Chemotherapy, 2007
- Synthesis, stereochemistry and antimicrobial evaluation of some N-morpholinoacetyl-2,6-diarylpiperidin-4-onesEuropean Journal of Medicinal Chemistry, 2007
- Advances in combating fungal diseases: vaccines on the thresholdNature Reviews Microbiology, 2006
- In Vitro Activities of 5-Fluorocytosine against 8,803 Clinical Isolates of Candida spp.: Global Assessment of Primary Resistance Using National Committee for Clinical Laboratory Standards Susceptibility Testing MethodsAntimicrobial Agents and Chemotherapy, 2002
- Antifungal Efficacy of GM237354, a Sordarin Derivative, in Experimental Oral Candidiasis in Immunosuppressed RatsAntimicrobial Agents and Chemotherapy, 2001
- Mortality and Costs of Acute Renal Failure Associated with Amphotericin B TherapyClinical Infectious Diseases, 2001
- Anaphylactic reactions to liposomal amphotericinThe Lancet, 1994
- Calcineurin-dependent growth of an FK506- and CsA-hypersensitive mutant of Saccharomyces cerevisiaeJournal of General Microbiology, 1993
- Amphotericin B Blunts Erythropoietin Response to AnemiaThe Journal of Infectious Diseases, 1990